Methods in DNA Amplification pp 93-102 | Cite as
Qualitative and Quantitative Detection of Nucleic Acids of Infectious Agents by NASBA
Abstract
Since the advent of the polymerase chain reaction (PCR; Saki 1988; Mullis & Faloona 1987), a number of other nucleic acid amplification techniques have been developed. One of the most important and well developed of these new technologies is the Nucleic Acid Sequence Based Amplification (NASBATM method (Kievits et al 1991). NASBATM utilizes the coordinated activities of AMV reverse transcriptase (RT), RNase H, and T7 RNA polymerase to amplify a specific nucleic acid target. The specificity of the reaction is determined by a pair of oligonucleotide primers, which are specific for the sequence of interest. One of these primers (designated P1) is synthesized so as to include the promoter for T7 RNA polymerase as a 5’ overhang. The reaction is conducted at constant temperature (41°C) and produces a single stranded RNA product which represents a 106-109 amplification of the original target sequence (figure 1). Although capable of amplifying both DNA and RNA target sequences, NASBATM is most suitable for the amplification of RNA. Thus, NASBATM has become an extremely powerful technique for the detection and quantification of retroviruses (particularly HIV-1).
Keywords
Human Immunodeficiency Virus Type Horse Radish Peroxidase Nucleic Acid Amplification Blood Fraction Nucleic Acid Amplification TechniquePreview
Unable to display preview. Download preview PDF.
References
- Boom R., Sol C J A, Salimans M M M, Jansen C L, Wertheim - van Dillen P M E and van der Noordaa J. Rapid and simple method for purification of nucleic acids.J Clin Microbiol 1990, 28: 495–503.PubMedGoogle Scholar
- Bruisten S, van Gemen B, Koppelman M, Rasch M, van Strijp D, Schukkink R, Beyer R, Weigel H, Lens P and Huisman H. Distribution of HIV-1 in different blood fractions of HIV-1 seropositive persons using two nucleic acid amplification assays. AIDS Hum Retrovir.In press.Google Scholar
- Ho D.D., Moudgil T and Alam H. Quantification of human immunodeficiency virus type 1 in the blood of infected persons. New Eng. J. Med. 1989, 321: 1621–1625.PubMedCrossRefGoogle Scholar
- Kievits T, van Gemen B, van Strijp D, Schukkink R, Dircks M, Adriaanse H, Malek L, Sooknanan R and Lens P. NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol Meth. 1991, 35: 273–286.CrossRefGoogle Scholar
- Larder B.A., Darby G and Richman D D. HIV with reduced senstivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989, 243: 1731.PubMedCrossRefGoogle Scholar
- Mullis K.B. and Faloona F A. Specific synthesis ofDNA in vitro via a polymerase catalyzed chain reaction. Methods Enzymol 1987, 155: 335–350.PubMedCrossRefGoogle Scholar
- Nishanian P, Huskins K R, Stehn S, Detels R and. Fahey J L. A simple method for improved assay demonstrates that p24 antigen is presnt as immune complexes in most sera from HIV-infected individuals. J. Inf. Dis. 1990, 162: 21–28.CrossRefGoogle Scholar
- Pantaleo G., Graziosi C, Butini L, Pizzo PA, Schittman S M, Kotler D P and Fanci A S. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 1991, 88: 9838–9842.PubMedCrossRefGoogle Scholar
- Saiki R K, Gelfand D H, Stoffel S, Scharf S J, Higuchi R, Horn G T, Mullis K B and Ehrlich H A. Primer-dependent enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988, 239: 487–491.Google Scholar
- Zack J.A., Arrigo S J, Weitsman S R, Go A S, Haislip A and Chen ISY. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile latent viral structure. Cell 1990, 61: 213–222.PubMedCrossRefGoogle Scholar